{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:48:09Z","timestamp":1791938889012,"version":"4.3.4"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"WHO TB Supranational Reference Laboratory, Johannesburg, South Africa","award":["GRANT004_94640"],"award-info":[{"award-number":["GRANT004_94640"]}]},{"DOI":"10.13039\/501100001866","name":"National Research Fund","doi-asserted-by":"publisher","award":["SFH150723130071"],"award-info":[{"award-number":["SFH150723130071"]}],"id":[{"id":"10.13039\/501100001866","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001343","name":"University of Pretoria","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001343","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiological Methods"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.mimet.2018.08.011","type":"journal-article","created":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T02:34:07Z","timestamp":1535423647000},"page":"1-9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["In vitro approaches for generation of Mycobacterium tuberculosis mutants resistant to bedaquiline, clofazimine or linezolid and identification of associated genetic variants"],"prefix":"10.1016","volume":"153","author":[{"given":"N.","family":"Ismail","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.V.","family":"Omar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.A.","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2124-7275","authenticated-orcid":false,"given":"R.P.H.","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mimet.2018.08.011_bb0005","doi-asserted-by":"crossref","first-page":"679","DOI":"10.5588\/ijtld.14.0768","article-title":"Pyrazinamide resistance in Mycobacterium tuberculosis arises after rifampicin and fluoroquinolone resistance","volume":"19","author":"Alame-Emane","year":"2015","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"10.1016\/j.mimet.2018.08.011_bb0010","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1126\/science.1106753","article-title":"A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis","volume":"307","author":"Andries","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.mimet.2018.08.011_bb0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0102135","article-title":"Acquired resistance of Mycobacterium tuberculosis to bedaquiline","volume":"9","author":"Andries","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.mimet.2018.08.011_bb0020","series-title":"Reference Strains: How Many Passages Are Too Many?","author":"ATCC","year":"2013"},{"key":"10.1016\/j.mimet.2018.08.011_bb0025","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1128\/AAC.01903-13","article-title":"Bactericidal activity and mechanism of action of AZD5847, a novel oxazolidinone for treatment of tuberculosis","volume":"58","author":"Balasubramanian","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.mimet.2018.08.011_bb0030","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1128\/AAC.06227-11","article-title":"rplC T460C identified as a dominant mutation in linezolid-resistant Mycobacterium tuberculosis strains","volume":"56","author":"Beckert","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.mimet.2018.08.011_bb0035","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/jac\/dkp237","article-title":"Resistant mutants of Mycobacterium tuberculosis selected in vitro do not reflect the in vivo mechanism of isoniazid resistance","volume":"64","author":"Bergval","year":"2009","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.mimet.2018.08.011_bb0040","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1186\/s12864-015-2067-2","article-title":"Whole genome sequencing reveals genomic heterogeneity and antibiotic purification in Mycobacterium tuberculosis isolates","volume":"16","author":"Black","year":"2015","journal-title":"BMC Genomics"},{"key":"10.1016\/j.mimet.2018.08.011_bb0045","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1056\/NEJMc1505196","article-title":"Acquired resistance to bedaquiline and delamanid in therapy for tuberculosis","volume":"373","author":"Bloemberg","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mimet.2018.08.011_bb0050","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/ng.811","article-title":"Use of whole genome sequencing to estimate the mutation rate of Mycobacterium tuberculosis during latent infection","volume":"43","author":"Ford","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.mimet.2018.08.011_bb0055","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1128\/AAC.46.2.267-274.2002","article-title":"Evolution of drug resistance in Mycobacterium tuberculosis: clinical and molecular perspective","volume":"46","author":"Gillespie","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.mimet.2018.08.011_bb0060","series-title":"Mycobacteriology Laboratory Manual","first-page":"51","author":"GLI, Global Laboratory Initiative","year":"2014"},{"key":"10.1016\/j.mimet.2018.08.011_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002158","article-title":"Selection of resistant bacteria at very low antibiotic concentrations","volume":"7","author":"Gullberg","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.mimet.2018.08.011_bb0070","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/femsre\/fux011","article-title":"Antimicrobial resistance in Mycobacterium tuberculosis: mechanistic and evolutionary perspectives","volume":"41","author":"Gygli","year":"2017","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.mimet.2018.08.011_bb0075","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1128\/AAC.00037-14","article-title":"Cross-resistance between clofazimine and bedaquiline through upregulation of MmpL5 in Mycobacterium tuberculosis","volume":"58","author":"Hartkoorn","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.mimet.2018.08.011_bb0080","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1128\/AAC.01189-07","article-title":"In vitro-selected linezolid-resistant Mycobacterium tuberculosis mutants","volume":"52","author":"Hillemann","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.mimet.2018.08.011_bb0085","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1128\/AAC.01611-09","article-title":"Rates and mechanisms of resistance development in Mycobacterium tuberculosis to a novel diarylquinoline ATP synthase inhibitor","volume":"54","author":"Huitric","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.mimet.2018.08.011_bb0090","series-title":"Catalog of Previously Published Mutations and Mutation Frequencies Associated with Bedaquiline, Clofazimine and Linezolid Resistance for Mycobacterium tuberculosis","author":"Ismail","year":"2018"},{"key":"10.1016\/j.mimet.2018.08.011_bb0095","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0140-6736(14)62450-8","article-title":"Drug-resistance mechanisms and tuberculosis drugs","volume":"385","author":"Koser","year":"2015","journal-title":"Lancet (Lond., Engl.)"},{"key":"10.1016\/j.mimet.2018.08.011_bb0100","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/genetics\/28.6.491","article-title":"Mutations of bacteria from virus sensitivity to virus resistance","volume":"28","author":"Luria","year":"1943","journal-title":"Genetics"},{"key":"10.1016\/j.mimet.2018.08.011_bb0105","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1128\/AAC.00152-16","article-title":"Role of the Cys154Arg substitution in ribosomal protein L3 in oxazolidinone resistance in Mycobacterium tuberculosis","volume":"60","author":"Makafe","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.mimet.2018.08.011_bb0110","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1128\/AAC.44.7.1771-1777.2000","article-title":"Mutation frequencies and antibiotic resistance","volume":"44","author":"Martinez","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.mimet.2018.08.011_bb0115","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.coph.2011.07.005","article-title":"Beyond serial passages: new methods for predicting the emergence of resistance to novel antibiotics","volume":"11","author":"Martinez","year":"2011","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.mimet.2018.08.011_bb0120","doi-asserted-by":"crossref","first-page":"849","DOI":"10.2217\/fmb.10.50","article-title":"TMC207: the first compound of a new class of potent anti-tuberculosis drugs","volume":"5","author":"Matteelli","year":"2010","journal-title":"Future Microbiol"},{"key":"10.1016\/j.mimet.2018.08.011_bb0125","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/jac\/dkt364","article-title":"Mutation rate and the emergence of drug resistance in Mycobacterium tuberculosis","volume":"69","author":"McGrath","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.mimet.2018.08.011_bb0130","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1513\/AnnalsATS.201509-632PS","article-title":"Treatment of tuberculosis. A historical perspective","volume":"12","author":"Murray","year":"2015","journal-title":"Ann. Am. Thorac. Soc."},{"key":"10.1016\/j.mimet.2018.08.011_bb0135","series-title":"Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes","first-page":"23","author":"NCCLS","year":"2003"},{"issue":"10","key":"10.1016\/j.mimet.2018.08.011_bb0140","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1093\/cid\/cix992","article-title":"Bedaquiline resistance: its emergence, mechanism and prevention","volume":"66","author":"Nguyen","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.mimet.2018.08.011_bb0145","series-title":"South African Tuberculosis Drug Resistance Survey","author":"NICD, National Institute for Communicable Diseases","year":"2012"},{"key":"10.1016\/j.mimet.2018.08.011_bb0150","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.advms.2015.09.007","article-title":"Pyrazinamide resistance in Mycobacterium tuberculosis: review and update","volume":"61","author":"Njire","year":"2016","journal-title":"Adv. Med. Sci."},{"key":"10.1016\/j.mimet.2018.08.011_bb0155","article-title":"Whole Genome Sequencing for drug resistance determination of Mycobacterium tuberculosis","author":"Omar","year":"2018","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.mimet.2018.08.011_bb0160","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1128\/AAC.00244-06","article-title":"Genetic basis for natural and acquired resistance to the diarylquinoline R207910 in mycobacteria","volume":"50","author":"Petrella","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.mimet.2018.08.011_bb0165","doi-asserted-by":"crossref","first-page":"4188","DOI":"10.1128\/JCM.02283-12","article-title":"Incubation time of mycobacterial cultures: how long is long enough to issue a final negative report to the clinician?","volume":"50","author":"Pfyffer","year":"2012","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.mimet.2018.08.011_bb0170","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1006\/meth.1999.0901","article-title":"Determining mutation rates in bacterial populations","volume":"20","author":"Rosche","year":"2000","journal-title":"Methods (San Diego, Calif.)"},{"key":"10.1016\/j.mimet.2018.08.011_bb0175","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1021\/acsinfecdis.6b00051","article-title":"Prediction of Drug Penetration in Tuberculosis Lesions","volume":"2","author":"Sarathy","year":"2016","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.mimet.2018.08.011_bb0180","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1128\/AAC.06154-11","article-title":"New mutations in the mycobacterial ATP synthase: new insights into the binding of the diarylquinoline TMC207 to the ATP synthase C-ring structure","volume":"56","author":"Segala","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.mimet.2018.08.011_bb0185","series-title":"MGIT\u2122 Procedure Manual for BACTEC\u2122 MGIT 960\u2122 TB System","author":"Siddiqi","year":"2006"},{"key":"10.1016\/j.mimet.2018.08.011_bb0190","first-page":"684","article-title":"Unexpected high prevalence of resistance-associated Rv0678 variants in MDR-TB patients without documented prior use of clofazimine or bedaquiline","volume":"72","author":"Villellas","year":"2017","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.mimet.2018.08.011_bb0195","series-title":"Global Tuberculosis Report","author":"WHO","year":"2017"},{"key":"10.1016\/j.mimet.2018.08.011_bb0200","series-title":"Technical Report on Critical Concentrations for TB Drug Susceptibility Testing of Medicines Used in the Treatment of Drug-Resistant TB","author":"WHO","year":"2018"},{"key":"10.1016\/j.mimet.2018.08.011_bb0205","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1093\/jac\/dkv150","article-title":"Identification of novel mutations associated with clofazimine resistance in Mycobacterium tuberculosis","volume":"70","author":"Zhang","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.mimet.2018.08.011_bb0210","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1128\/AAC.02941-15","article-title":"Mycobacterium tuberculosis mutations associated with reduced susceptibility to linezolid","volume":"60","author":"Zhang","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.mimet.2018.08.011_bb0215","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1086\/315708","article-title":"Selection of antibiotic-resistant bacterial mutants: allelic diversity among fluoroquinolone-resistant mutations","volume":"182","author":"Zhou","year":"2000","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.mimet.2018.08.011_bb0220","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/S1473-3099(16)30190-6","article-title":"Population-based resistance of Mycobacterium tuberculosis isolates to pyrazinamide and fluoroquinolones: results from a multicountry surveillance project","volume":"16","author":"Zignol","year":"2016","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.mimet.2018.08.011_bb0225","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1093\/jac\/dkx094","article-title":"Examination of bedaquiline- and linezolid-resistant Mycobacterium tuberculosis isolates from the Moscow region","volume":"72","author":"Zimenkov","year":"2017","journal-title":"J. Antimicrob. Chemother."}],"container-title":["Journal of Microbiological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167701218305372?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167701218305372?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T23:56:30Z","timestamp":1759103790000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167701218305372"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":45,"alternative-id":["S0167701218305372"],"URL":"https:\/\/doi.org\/10.1016\/j.mimet.2018.08.011","relation":{},"ISSN":["0167-7012"],"issn-type":[{"value":"0167-7012","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro approaches for generation of Mycobacterium tuberculosis mutants resistant to bedaquiline, clofazimine or linezolid and identification of associated genetic variants","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mimet.2018.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}